Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Ovarian Cancer.

Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Soft Tissue Sarcoma.

Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea ...

University of Texas at Austin, Department of Chemistry, 105 E 24th St., Welch Hall (A5300), Austin, Texas 78712, United States ...